## Abstract We have examined the application of ^90^YโDOTAโcPAM4, antiโMUC1 IgG, in combination with the frontโline drug gemcitabine as a potential therapeutic for pancreatic cancer. Athymic nude mice bearing CaPan1 human pancreatic cancer xenografts were administered 2 mg of gemcitabine on days 0,
Use of an yttrium 90 labeled antibody for the treatment of human colon cancer xenografts in nude mice
โ Scribed by Craig S. Heacock; Ann M. Blake; Christopher J. D'Aleo; Vernon L. Alvarez
- Publisher
- Elsevier Science
- Year
- 1988
- Weight
- 60 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0883-2889
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. The purpose of this investigation was to compare the therapeutic Rhona Stein, Ph
Colorectal cancer frequently disseminates through the portal vein into the liver. In this study, outbred Swiss nude mice were adapted to facilitate the induction of liver metastases by a pre-grafting treatment with 6 Gy total body irradiation and i.v.
Anti-CEA antibodies were used for radio-immunotherapy in an established LS174T colonic xenograft in nude mice. A single IV dose of either I3'I-PK4S (polyclonal) or -A5B7 (monoclonal) antibody produced tumour regression, and sig- nificantly delayed subsequent tumour growth. Administration of a cleari
## Abstract Carbonic anhydrase IX (CA IX) is frequently expressed in human carcinomas and absent from the corresponding normal tissues. Strong induction by tumor hypoxia predisposes CA IX to serve as a target for cancer diagnostics and therapy. Here we evaluated targeting properties and pharmacokin